Want to see IN:ZYDUSWELL full AI Analyst Report?
Top Page
Zydus Wellness Limited
(ZYDUSWELL)
Select Model
Select Model
Rating:47Neutral
Price Target:
₹500.00
▲(17.67% Upside)
Action:Reiterated
Date:10/01/26
The score is held back primarily by weakened earnings quality—sharp margin compression, reduced cash generation/cash conversion, and a step-up in leverage—despite strong FY2026 revenue growth. Technicals are also soft (below major moving averages with negative MACD), and valuation is a headwind due to a very high P/E and minimal dividend yield.
Positive Factors
Strong Revenue Growth
The sharp FY2026 acceleration shows strong demand and improved market traction across the business. If sustained, higher sales can expand distribution scale, support brand investment, and create a stronger base for recovering profitability over the next several quarters.
Negative Factors
Sharp Margin Compression
The sharp decline in net and EBIT margins indicates that strong sales growth is not currently translating proportionately into earnings. Persistent cost, pricing, or mix pressure would reduce reinvestment capacity and make future profit growth less dependable.
Read all positive and negative factors
Positive Factors
Negative Factors
Strong Revenue Growth
The sharp FY2026 acceleration shows strong demand and improved market traction across the business. If sustained, higher sales can expand distribution scale, support brand investment, and create a stronger base for recovering profitability over the next several quarters.
Read all positive factors
Zydus Wellness Limited (ZYDUSWELL) vs. iShares MSCI India ETF (INDA)
Market Cap
₹161.36B
Dividend Yield0.23%
Average Volume (3M)36.17K
Price to Earnings (P/E)86.6
Beta (1Y)0.89
Revenue Growth66.27%
EPS Growth-42.46%
CountryIN
Employees1,008
SectorGeneral
Sector StrengthN/A
IndustryPackaged Foods
Share Statistics
EPS (TTM)5.92
Shares Outstanding318,160,700
10 Day Avg. Volume23,766
30 Day Avg. Volume36,175
Financial Highlights & Ratios
PEG Ratio-1.59
Price to Book (P/B)2.33
Price to Sales (P/S)3.42
P/FCF Ratio345.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)11.46
Revenue Forecast (FY)₹53.12B
Zydus Wellness Limited Business Overview & Revenue Model
Company Description
Zydus Wellness Limited is an Indian firm dedicated to the creation, manufacturing, promotion, and distribution of health and wellness products. Their extensive product range encompasses popular sugar substitutes such as Sugar Free Gold, Sugar Free...
How the Company Makes Money
Zydus Wellness primarily makes money by selling branded health and wellness consumer products to distributors, retailers, and other trade partners, generating revenue from the invoiced sale of finished goods. Its key revenue streams are (1) brande...
Zydus Wellness Limited Financial Statement Overview
Summary
Income Statement
62
Positive
Balance Sheet
55
Neutral
Cash Flow
41
Neutral
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 45.30B | 39.61B | 27.09B | 23.28B | 22.55B | 20.09B |
| Gross Profit | 24.77B | 19.34B | 10.77B | 8.87B | 10.96B | 7.41B |
| EBITDA | 5.67B | 4.75B | 3.99B | 3.08B | 3.32B | 3.55B |
| Net Income | 1.88B | 1.97B | 3.47B | 2.67B | 3.10B | 3.09B |
Balance Sheet | ||||||
| Total Assets | 0.00 | 103.08B | 64.42B | 61.48B | 58.33B | 56.92B |
| Cash, Cash Equivalents and Short-Term Investments | 1.15B | 1.15B | 1.29B | 3.16B | 1.08B | 1.96B |
| Total Debt | 0.00 | 32.03B | 1.88B | 3.29B | 2.97B | 3.87B |
| Total Liabilities | -58.26B | 44.82B | 7.70B | 7.91B | 7.11B | 8.48B |
| Stockholders Equity | 58.26B | 58.26B | 56.72B | 53.58B | 51.23B | 48.44B |
Cash Flow | ||||||
| Free Cash Flow | 235.00M | 393.00M | 3.14B | 2.18B | 467.00M | 1.61B |
| Operating Cash Flow | 931.00M | 1.41B | 3.80B | 2.46B | 917.00M | 2.37B |
| Investing Cash Flow | -28.68B | -29.11B | -2.24B | -1.78B | -849.00M | -859.50M |
| Financing Cash Flow | 28.01B | 27.85B | -1.86B | -257.00M | -1.39B | -2.34B |
Zydus Wellness Limited Technical Analysis
Negative
424.90
Price Trends
534.92
Negative
532.24
Negative
484.88
Positive
Market Momentum
-4.55
Positive
39.50
Neutral
15.99
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:ZYDUSWELL, the sentiment is Negative. The current price of 424.9 is below the 20-day moving average (MA) of 537.00, below the 50-day MA of 534.92, and below the 200-day MA of 484.88, indicating a neutral trend. The MACD of -4.55 indicates Positive momentum. The RSI at 39.50 is Neutral, neither overbought nor oversold. The STOCH value of 15.99 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:ZYDUSWELL.
Zydus Wellness Limited Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ₹2.58T | 66.30 | ― | 0.91% | 19.30% | 22.64% | |
73 Outperform | ₹1.16T | 44.68 | ― | 1.88% | 6.63% | 18.70% | |
61 Neutral | ₹957.04B | 57.44 | ― | 1.05% | 15.60% | 22.76% | |
60 Neutral | ₹232.45B | 19.87 | ― | 0.56% | 16.68% | 0.97% | |
58 Neutral | ₹403.93B | 20.03 | ― | 1.78% | 19.32% | 61.42% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
47 Neutral | ₹161.36B | 86.62 | ― | 0.23% | 66.27% | -42.46% |
* General Sector Average
IN:ZYDUSWELL
Zydus Wellness Limited
512.85
54.07
11.78%
IN:AWL
Adani Wilmar Limited
177.70
-83.93
-32.08%
IN:BRITANNIA
Britannia Industries Ltd
4,810.90
-1,055.84
-18.00%
IN:NESTLEIND
Nestle India Ltd.
1,312.00
157.66
13.66%
IN:PATANJALI
Patanjali Foods Limited
363.00
-211.00
-36.76%
IN:TATACONSUM
Tata Consumer Products Limited
953.00
-180.96
-15.96%
Zydus Wellness Limited Corporate Events
Zydus Wellness Board Clears June Quarter Unaudited Results, Resets Trading Window
Aug 4, 2026
Zydus Wellness Limited’s Board of Directors, acting on the Audit Committee’s recommendations, has approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, in line with SEBI’s Listi...
Zydus Wellness Opens Special Window for Legacy Physical Share Transfers
Aug 1, 2026
Zydus Wellness Limited operates in the fast-moving consumer goods and healthcare-oriented wellness sector, offering a portfolio of nutrition, personal care and health products tailored to Indian consumers. The company is listed on both BSE and the...
Zydus Wellness Sets August 4 Virtual AGM, Tightens KYC and E-Voting Norms
Jul 12, 2026
Zydus Wellness has convened its 32nd Annual General Meeting for August 4, 2026, to be held via video conferencing and other audio-visual means, with all ordinary and special business to be conducted exclusively through electronic voting. The compa...
Zydus Wellness Subsidiary Fined by Polish Tax Authority for Intrastat Filing Delays
Jul 11, 2026
Zydus Wellness has disclosed that Comfort Click Limited, its step-down wholly owned subsidiary in the United Kingdom, has received an order from the Polish tax authority alleging delays in filing Intrastat declarations for stock movements between ...
Zydus Wellness Senior Sales Head Resigns, Transition Planned to Protect Operations
Jul 3, 2026
Zydus Wellness Limited has announced the resignation of senior management member Lalit Ahuja, who served as Head – Sales for India and ISC, effective at the close of business on July 3, 2026. The company disclosed the development under SEBI&...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.